1-16 of 16
Tak Takvorian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Ibrutinib Maintenance (I-M) Following Frontline Induction in Mantle Cell Lymphoma (MCL) with Sequential Assessment of Changes in NGS-MRD

Reem Karmali, Jeremy S. Abramson, Deborah M. Stephens, Jeffrey A Barnes, Jason Kaplan, Jane N. Winter, Shuo Ma, Juehua Gao, Adam M Petrich, Ephraim Hochberg, Tak Takvorian, Frank Kuhr, Lik Wee Lee, Valerie Nelson, Leo I. Gordon, Barbara Pro
Journal: Blood
Blood (2021) 138 (Supplement 1): 3530.
https://doi.org/10.1182/blood-2021-144707
Published: 2021
Journal Articles

Zanubrutinib, Obinutuzumab, and Venetoclax in Chronic Lymphocytic Leukemia: Early MRD Kinetics Define a High-Risk Patient Cohort with Delayed Bone Marrow Undetectable MRD and Earlier Post-Treatment MRD Recurrence

Jacob D. Soumerai, Anthony R. Mato, Ahmet Dogan, Venkatraman Seshan, Erel Joffe, Kelsey Flaherty, Jason Carter, Ephraim P Hochberg, Jeffrey A Barnes, Audrey Hamilton, Jeremy S. Abramson, Connie Lee Batlevi, Matthew J. Matasar, Ariela Noy, Colette Owens, M. Lia Palomba, Anita Kumar, Tak Takvorian, Ai Ni, Morgan Choma, Chaya Friedman, Puja Chadha, Elizabeth Simkins, Jade Ruiters, Sidney Sechio, Daneal Portman, Natascha Nolet, Neena Mahajan, Rosalba Martignetti, Joanna Mi, Krista J Scorsune, Julia M Lynch, Brianne McGree, Stephanie Y Hughes, Clare Grieve, Lindsey E. Roeker, Meghan C. Thompson, P. Connor Johnson, Mikhail Roshal, Jane Huang, Juliana M.L. Biondo, Jenny Qun Wu, Allison P. Jacob, Omar Abdel-Wahab, Andrew D. Zelenetz
Journal: Blood
Blood (2021) 138 (Supplement 1): 3753.
https://doi.org/10.1182/blood-2021-150961
Published: 2021
Journal Articles

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphomas: Final Results from a Phase 1-2 Trial

Jeremy S. Abramson, MD, Eric D. Jacobsen, MD, Robert Allyn Redd, MS, Tak Takvorian, MD, David C. Fisher, MD, Jennifer R. Brown, Joel H Schwartz, MD, James Weitzman, MD, Donna Neuberg, ScD, Jeffrey A. Barnes, MD PhD, Ephraim P Hochberg, MD
Journal: Blood
Blood (2014) 124 (21): 4423.
https://doi.org/10.1182/blood.V124.21.4423.4423
Published: 2014
Journal Articles

Panobinostat in Combination with Rituximab in Heavily Pretreated Diffuse Large B-Cell Lymphoma: Results of a Phase II Study

Jeffrey A. Barnes, MD PhD, Robert Allyn Redd, MS, Eric D. Jacobsen, MD, David C. Fisher, MD, Arnold S. Freedman, MD, Ephraim P Hochberg, MD, Tak Takvorian, MD, Donna Neuberg, ScD, Jeremy S. Abramson, MD
Journal: Blood
Blood (2014) 124 (21): 3055.
https://doi.org/10.1182/blood.V124.21.3055.3055
Published: 2014
Journal Articles

Ofatumumab As Initial Therapy For Indolent B Cell Lymphomas: A Phase II Trial

Jeffrey A. Barnes, MD, PhD, Yang Feng, PhD, Ephraim P Hochberg, MD, Tak Takvorian, MD, James Weitzman, MD, David C. Fisher, MD, Eric D. Jacobsen, MD, Robin Joyce, MD, Donna S. Neuberg, ScD, Jeremy S. Abramson, MD
Journal: Blood
Blood (2013) 122 (21): 3062.
https://doi.org/10.1182/blood.V122.21.3062.3062
Published: 2013
Journal Articles

Double Hit Lymphomas: Evaluation of Prognostic Factors and Impact of Therapy

Jeremy S. Abramson, MD, Jeffrey A. Barnes, MD, PhD, Yang Feng, PhD, Tak Takvorian, MD, Donna S. Neuberg, ScD, Ephraim P. Hochberg, MD, Aliyah R. Sohani, MD
Journal: Blood
Blood (2012) 120 (21): 1619.
https://doi.org/10.1182/blood.V120.21.1619.1619
Published: 2012
Journal Articles

High Rate of Initial Treatment Failure in Patients with Primary Mediastinal B-Cell Lymphoma Treated with R-CHOP

Jeremy S. Abramson, MD, Matthew D Hellmann, MD, Yang Feng, PhD, Jeffrey A. Barnes, MD, PhD, Tak Takvorian, MD, Christiana E. Toomey, Michael Sheppard, James S. Michaelson, PhD, Donna Neuberg, ScD, Ephraim P. Hochberg, MD
Journal: Blood
Blood (2011) 118 (21): 1601.
https://doi.org/10.1182/blood.V118.21.1601.1601
Published: 2011
Journal Articles

Increased Dose Rituximab Followed by Maintenance Rituximab As Initial Therapy for Indolent B Cell Lymphomas: A Phase II Trial,

Jeffrey A. Barnes, MD, PhD, Kristen Stevenson, Ephraim P. Hochberg, MD, Tak Takvorian, MD, David C. Fisher, MD, Ann LaCasce, MD, Jennifer R. Brown, MD, PhD, Anuj K. Mahindra, MD, Donna Neuberg, ScD, Jeremy S. Abramson, MD
Journal: Blood
Blood (2011) 118 (21): 3716.
https://doi.org/10.1182/blood.V118.21.3716.3716
Published: 2011
Journal Articles

A Phase I Dose-Escalation Trial of Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

Jeremy S Abramson, MD, Tak Takvorian, MD, Eric D Jacobsen, MD, Jennifer R Brown, MD, PhD, Jeffrey A. Barnes, MD, PhD, Yang Feng, Donna Neuberg, ScD, Ephraim P. Hochberg, MD
Journal: Blood
Blood (2010) 116 (21): 1775.
https://doi.org/10.1182/blood.V116.21.1775.1775
Published: 2010
Journal Articles

Response to Dasatinib In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Correlates with p-Lyn and p-Syk

Philip C. Amrein, MD, Eyal C Attar, MD, Tak Takvorian, M.D., Ephraim Hochberg, Karen K Ballen, MD, Kathleen M Leahy, David C. Fisher, MD, Ann LaCasce, MD, MSc, Eric D Jacobsen, MD, Philippe Armand, MD, PhD, Robert Hasserjian, MD, Lillian Werner, Donna Neuberg, ScD, Jennifer R Brown, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2457.
https://doi.org/10.1182/blood.V116.21.2457.2457
Published: 2010
Journal Articles

Dasatinib Has Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL/SLL), a Phase II Trial

Philip C. Amrein, MD, Eyal Attar, MD, Tak Takvorian, M.D., Ephraim Hochberg, Karen K. Ballen, MD, Kathleen M. Leahy, Donna Neuberg, ScD, Jennifer R. Brown, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3162.
https://doi.org/10.1182/blood.V112.11.3162.3162
Published: 2008
Journal Articles

Rituximab Added to CODOX-M/IVAC Is Highly Effective in HIV-Negative and hiv-Positive Burkitt Lymphoma

Jeremy S. Abramson, MD, Jeffrey A. Barnes, M.D., Christiana E. Toomey, Eric D. Jacobsen, MD, Philippe Armand, Tak Takvorian, MD, David C. Fisher, MD, Hazel Reynolds, Ephraim P. Hochberg, Ann S. LaCasce, MD
Journal: Blood
Blood (2008) 112 (11): 3595.
https://doi.org/10.1182/blood.V112.11.3595.3595
Published: 2008
Journal Articles

A Phase II Study of Dasatinib in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL/SLL).

Philip C. Amrein, MD, Eyal C. Attar, M.D., Tak Takvorian, M.D., Ephraim P. Hochberg, M.D., Karen Ballen, M.D., David Zahrieh, M.S., Jennifer R. Brown, M.D.
Journal: Blood
Blood (2007) 110 (11): 3126.
https://doi.org/10.1182/blood.V110.11.3126.3126
Published: 2007
Journal Articles

Intermediate Dose Intravenous Methotrexate (MTX) Dramatically Reduces the Risk of Secondary Central Nervous System (CNS) Lymphoma.

Ephraim P. Hochberg, MD, Peter Hammerman, MD, Tak Takvorian, MD, Christiana Toomey, James Michaelson, PhD, Aliyah Rahemtullah, MD, Jeremy S. Abramson, MD
Journal: Blood
Blood (2007) 110 (11): 3442.
https://doi.org/10.1182/blood.V110.11.3442.3442
Published: 2007
Journal Articles

High False Positive Rate with the Use of CT and FDG-PET in Post-Remission Surveillance for Hodgkin Lymphoma.

Dan Zuckerman, MD, Ann Lacasce, MD, Eric Jacobsen, MD, Tak Takvorian, MD, Ephraim Hochberg, MD
Journal: Blood
Blood (2007) 110 (11): 2327.
https://doi.org/10.1182/blood.V110.11.2327.2327
Published: 2007
Journal Articles

Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma

Arnold S. Freedman, Donna Neuberg, Peter Mauch, Robert J. Soiffer, Kenneth C. Anderson, David C. Fisher, Robert Schlossman, Edwin P. Alyea, Tak Takvorian, Haddy Jallow, Caroline Kuhlman, Jerome Ritz, Lee M. Nadler, John G. Gribben
Journal: Blood
Blood (1999) 94 (10): 3325–3333.
https://doi.org/10.1182/blood.V94.10.3325.422k13_3325_3333
Published: 1999